Literature DB >> 7449744

Adenylate cyclase activation and competitive binding with renal tissue using synthetic eel calcitonin analog and its fragments.

I Yamamoto, R Morita, M Fukunaga, S Dokoh, C Shigeno, K Torizuka, T Noda.   

Abstract

The structure-function relationship of calcitonin (CT) was investigated using a synthetic eel CT (E-CT) analog and its fragments. Adenylate cyclase activation and competitive binding to rat renal receptors were used as parameters of function. [Asu1,7]E-CT analog, synthesized by replacing the S-S bond of Cys1-Cys7 in the natural hormone with ethylene linkage of 1-amino suberic acid (Asu), and E-CT fragment 11-32 had about 1/5th and 1/50th the potencies of synthetic E-CT, respectively, in both adenylate cyclase activation and competitive inhibition of 125I-labeled [Asu1,7]iodo-E-CT binding on rat renal plasma membranes. The minimal chain length required to activate adenylate cyclase in rat renal plasma membranes was between 12-18 amino acids, and the minimal chain length required to affect the CT receptor binding was between 6-12 amino acids, near the C-terminus. Fragments, including the C-terminus, show a disproportionate and potent inhibition of the binding compared with the potency required for adenylate cyclase activation. Thus, the amino acid sequence near the C-terminus probably plays an important role in the binding of CT to the receptor. (Endocrinology 108: 698, 1981.)

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7449744     DOI: 10.1210/endo-108-2-698

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Relationships among several different non-homologous polypeptide hormones.

Authors:  R M Epand
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

2.  Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis.

Authors:  J Iwamoto; K Makita; Y Sato; T Takeda; H Matsumoto
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

3.  Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary.

Authors:  J A Fischer; P H Tobler; M Kaufmann; W Born; H Henke; P E Cooper; S M Sagar; J B Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

4.  Effect of human calcitonin (hCT) on glucose- and arginine-stimulated insulin secretion.

Authors:  S Sgambato; N Passariello; G Paolisso; A Marano; R Buoninconti; P Tesauro
Journal:  Acta Diabetol Lat       Date:  1986 Jan-Mar

5.  Accelerators of osteogenesis by recombinant human bone morphogenetic protein-2.

Authors:  Yasunori Okubo; Kenji Kusumoto; Kazuhisa Bessho
Journal:  Drug Target Insights       Date:  2007-02-21

6.  Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis.

Authors:  Jun Iwamoto; Mitsuyoshi Uzawa; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.